summari close report sale ep
ahead expect updat sales/ep
guidanc compani report ep ahead
consensu forecast ep upsid vs model
primarili reflect higher total revenu gross margin partli
off-set higher opex total revenu grew pro forma
pf beat estim guidanc
tighten sale rang sent clear messag expect
growth acceler coopervis
csi coopersurg bottom-lin ep
remain unchang absorb less
favor fx tailwind off-set underli strength
busi net-net believ manag sound
confid growth outlook busi
optimist momentum overal contact len market
estim total revenu ep
lower price target base
ep estim
sale ep exceed consensu forecast
report total revenu pf growth
improv sale pf
growth essenti in-lin model continu strong
growth daili segment region america grew
low-singl digit past three quarter
emea growth bit softer due tougher comp
compani note grey market activ europ larg
behind suggest expect america growth
continu improv emea growth may subdu csi
revenu grew pf includ contribut
recent lifeglob acquisit paragard sale
y/i pf beat estim ivf busi exclud
genet test grew genet
test segment continu see price pressur result y/i
sale declin gross margin beat estim
opex estim ep
beat estim consensu
continu next page
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
compani prioriti stock list
compani data secur llc estim reuter
continu previou page
guidanc updat sale rang tighten unchang ep absorb fx impact
expect revenu repres pf growth unchang
compani tighten revenu rang pf growth
pf growth reflect manag confid growth outlook csi revenu
outlook unchang although impli pf growth slightli better flat
vs flat within unchang csi guidanc lifeglob acquisit includ deal
close earli april ad sale offset sale loss associ coo decis
discontinu certain genet test product ep guidanc maintain
rang absorb less favor fx headwind fx benefit expect
revenu ep vs previou respect believ manag
sound confid updat sale ep guidanc
growth expect acceler csi coo sale grew pf
guidanc impli acceler growth high-singl digit year manag
expect pf growth improv year growth expect
improv driver growth acceler includ easier y/i comp
improv outlook america improv momentum silicon hydrogel daili franchis
csi compani expect pf growth improv sequenti perform
like stronger sens new ceo optimist busi
outlook confid abil execut
expect cl market growth momentum continu accord global contact len cl
model exclud bausch market grew similar growth data suggest
market growth may acceler nearli led jnj strong perform
adjust growth adjust custom stock manag estim global
cl market grow recent period continu grow rang
forese futur sens look grow least line market although
compani expect continu take share certain segment potenti new competit launch
alcon bausch somewhat overhang believ strength underli market
bode well coo outlook
price target
price target base ep estim risk includ slower growth
contact len market increas competit stronger dollar tax reform
particip attract contact len market sale grow
strong portfolio lens across modal help compani continu take share
global medic devic compani develop manufactur market health care
product two divis coopervis produc contact lens account
revenu coopersurg women health busi contribut nearli revenu
coopervis player share billion global soft contact len market
revenu grew pro forma billion million end octob
growth growth vs soft cl chang fiscal year run november-octob captur model adjust currenc aim acquisition/divestitur growth pro forma sauflon acquisit start growth rel aggreg growth nvs/ciba growth adjust stock custom new distribut center sourc compani report secur llc estim medic technolog
